Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
AMI Pharm's AYP-101 Shows Promise in Phase 2 Trial, Signaling a Breakthrough in Nonsurgical Fat Reduction 2025-09-01 21:00
Jenscare, releases 2025H1 interim results 2025-09-01 13:00
Jacobio Pharma Announces 2025 Interim Results 2025-08-30 00:25
United Imaging Healthcare Reports 2025H1 Financial Results: Achieves Record Revenue in Overseas market 2025-08-29 20:00
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market 2025-08-29 19:30
Taiwan's Smart Healthcare Pavilion Presents Precision Oncology and Telemedicine Applications at Taiwan Expo USA 2025 2025-08-29 17:32
Celaid Therapeutics have executed a collaborative research agreement with AGC on Expansion and Functional Evaluation of iPSC-HSPCs 2025-08-28 22:00
D3 Bio, Inc. Announces FDA Breakthrough Therapy Designation and Orphan Drug Designation for D3S-001 for the Treatment of Patients with KRAS G12C-Mutated Cancers 2025-08-28 21:00
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee 2025-08-28 20:00
Top Thermal Camera Manufacturer Raytron Makes Breakthroughs in Scientific Research 2025-08-28 14:00
FIRST CLINICAL EVIDENCE PUBLISHED ON AROA's ENIVO™ SYSTEM FOR SURGICAL DEAD SPACE MANAGEMENT. 2025-08-28 12:29
Ascletis Announces Favorable and Differentiated Pharmacokinetic Profile of ASC30 Oral Once-Daily Tablet in Its U.S. Phase Ib Multiple Ascending Dose Study 2025-08-28 07:45
Bestqool Honors Workers With Light-Based Recovery Solutions This Labor Day 2025-08-27 23:31
Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base Expand 2025-08-27 23:09
Harbour BioMed Reports 2025 Interim Results 2025-08-27 22:40
XtalPi Holdings Announces 2025 Interim Results 2025-08-27 22:23
Advancing DEL Technology for the Research Lab: HitGen Introduces OpenDEL™ 5.0 2025-08-27 21:30
NUHS SPEARHEADS AI-POWERED BRAIN CARE PROGRAMME TO TACKLE UNDERDIAGNOSIS AND IMPROVE PREVENTION OF DEMENTIA 2025-08-27 21:00
Actinogen trial using intended commercial Xanamem tablet formulation confirms target exposures in fed and fasted states 2025-08-27 20:00
Innovent Announces 2025 Interim Results and Business Updates 2025-08-27 18:08